Gene · 6372
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. | Nat Commun | 2022 | 36192482 | PubTator, text mining | PubMed |
| IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. | Front Immunol | 2022 | 36189314 | PubTator, text mining | PubMed |
| Identification and validation of key molecules associated with humoral immune modulation in Parkinson's disease based on bioinformatics. | Front Immunol | 2022 | 36189230 | PubTator, text mining | PubMed |
| Construction of a neural network diagnostic model and investigation of immune infiltration characteristics for Crohn's disease. | Front Genet | 2022 | 36186439 | PubTator, text mining | PubMed |
| MAPK activated kinase 2 inhibition shifts the chemokine signature in arthritis synovial fluid mononuclear cells from CXCR3 to CXCR2. | Int Immunopharmacol | 2022 | 36179420 | PubTator, text mining | PubMed |
| Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells. | Microb Pathog | 2022 | 36174833 | PubTator, text mining | PubMed |
| Risk Factors and Preventive Measures for Anastomotic Leak in Colorectal Cancer. | Technol Cancer Res Treat | 2022 | 36172641 | PubTator, text mining | PubMed |
| HOXA5-Mediated Stabilization of IκBα Inhibits the NF-κB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells. | Cancer Res | 2022 | 36166646 | PubTator, text mining | PubMed |
| How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities? | Front Immunol | 2022 | 36164340 | PubTator, text mining | PubMed |
| CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance. | Int J Inflam | 2022 | 36164329 | PubTator, text mining | PubMed |
| Gene therapy to enhance angiogenesis in chronic wounds. | Mol Ther Nucleic Acids | 2022 | 36159590 | PubTator, text mining | PubMed |
| Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma. | Front Oncol | 2022 | 36158683 | PubTator, text mining | PubMed |
| The angiogenic genes predict prognosis and immune characteristics in esophageal squamous cell carcinoma: Evidence from multi-omics and experimental verification. | Front Oncol | 2022 | 36158681 | PubTator, text mining | PubMed |
| Targeted plasma proteomics reveals upregulation of distinct inflammatory pathways in people living with HIV. | iScience | 2022 | 36157576 | PubTator, text mining | PubMed |
| The immunotoxicity of natural and depleted uranium: From cells to people. | Toxicol Appl Pharmacol | 2022 | 36152676 | PubTator, text mining | PubMed |
| Inflammatory and Proliferative Pathway Activation in Human Esophageal Myofibroblasts Treated with Acidic Bile Salts. | Int J Mol Sci | 2022 | 36142285 | PubTator, text mining | PubMed |
| Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer. | Genes (Basel) | 2022 | 36140808 | PubTator, text mining | PubMed |
| Camellia sinensis L. Alleviates Pulmonary Inflammation Induced by Porcine Pancreas Elastase and Cigarette Smoke Extract. | Antioxidants (Basel) | 2022 | 36139757 | PubTator, text mining | PubMed |
| Iron accelerates Fusobacterium nucleatum-induced CCL8 expression in macrophages and is associated with colorectal cancer progression. | JCI Insight | 2022 | 36136589 | PubTator, text mining | PubMed |
| Localized PD-1 Blockade in a Mouse Model of Renal Cell Carcinoma. | Front Drug Deliv | 2022 | 36132332 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6372/papers?page=38